ArticlePloS one2022

The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects.

Victoria Cairoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.